Heat Therapy and Cardiometabolic Health in Obese Women (CMH)
Obesity, Polycystic Ovary Syndrome, Prehypertension
About this trial
This is an interventional prevention trial for Obesity focused on measuring heat therapy, blood pressure, oral glucose tolerance test, adipose tissue, muscle sympathetic nerve activity
Eligibility Criteria
Inclusion Criteria:
- Age 18-40
- Body mass index (BMI) between 30-45 kg/m2.
- Willing to maintain consistent diet and activity patterns through the study
- Willing to refrain from food, physical activity, supplements, and medications as required before testing days
- Willing to refrain from blood donations over the course of the study
Exclusion Criteria:
- overt cardiovascular disease or diabetes
- medications that affect blood vessel function (i.e. Spironolactone), insulin sensitivity (Metformin), or blood coagulation (i.e. Warfarin)
- Recent rectal, anal, or vaginal surgery
- pregnant, breastfeeding, or trying to conceive within 6 months.
Sites / Locations
- University of Oregon
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Heat Therapy
Time Control
Subjects assigned to heat therapy underwent 30 1-hour hot tub sessions over 8-10 weeks (3-4 per week). The hot tub was set to 40.5 Celsius, and core temperature and heart rate were monitored throughout each session.Subjects were instructed to not make any other dietary or lifestyle changes.Cardiovascular and metabolic health assessments were made Pre (0 heat sessions), mid (after 14-16 heat sessions, ~4-5 weeks), and post (after all 30 heat sessions; ~8-10 weeks).
Subjects were monitored at matched timepoints (start of study, 4-5 weeks, and 8-10 weeks) but not exposed to any intervention. Subjects were instructed to not make any dietary or lifestyle changes.